Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2009
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Angiotensin Receptor Antagonists (MeSH)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Antihypertensive Agents (MeSH)
- Benzimidazoles (MeSH)
- Benzoates (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Trials as Topic (MeSH)
- Humans (MeSH)
- Telmisartan (MeSH)